Table 1 2012–2013 renal biopsy diagnoses. Sub-types of diseases are listed
Diagnosis | n | Male | Age (years) | Subtypes (n) |
|---|---|---|---|---|
MCD | 82 | 58% | 21.5 ± 15.8 | IgMN(2), FGGS(4) |
FSGS | 135 | 53% | 27.3 ± 17.6 | Collapsing(2) |
MGN | 71 | 46% | 37.1 ± 15.0 |  |
SLE | 51 | 16% | 30.5 ± 11.8 | Class I (3), II(3), III(9), IV(23), V(10), VI(3) |
IGAN | 28 | 61% | 29.5 ± 17.0 | Haas class I(3), II(8), III(7), IV(3), V(3), HSP(4) |
Crescentic GN | 26 | 54% | 37.1 ± 19.8 | Pauci-immune(21); crescentic class(6), mixed class(8), sclerotic class(7). AGBMD(2), ICD(3) |
MPGN | 12 | 75% | 37.8 ± 20.3 | Type 1(11), type2(0), cryoglobulinemia-associated(1) |
PSGN | 10 | 80% | 18.0 ± 19.5 |  |
Other GN | 18 | 56% | 29.9 ± 14.4 | MePGN(13), C1qN(2), fibril GN(1), diffuse mesangial sclerosis(1) Obesity-associated glomerulomegaly(1) |
CGN-NOS | 24 | 71% | 27.2 ± 14.0 |  |
HUS | 9 | 55% | 29.0 ± 20.5 | D+ (3), APL(1), PP(2) |
TIN | 46 | 55% | 32.9 ± 20.4 | acute pyelonephritis(6) |
arteriolosclerosis | 52 | 48% | 49.6 ± 15.2 |  |
Amyloidosis AL | 2 | 40% | 55.5 ± 0.7 | Myeloma(2) |
Amyloidosis AA | 19 | 40% | 40.2 ± 23.4 | RA(4), JRA(3), arthritis(2), SLE (1), FMF(1), asthma(1), bronchiectasis(3), unknown(4). |
Myeloma kidney | 4 | 50% | 59.3 ± 7.7 |  |
Diabetes | 5 | 40% | 47.0 ± 6.4 |  |
Other non-glomerular | 28 | 46% | 29.7 ± 14.7 | Acute kidney injury(14),basement membrane disease(2) CKD NOS (10), Fabry’s(1), scleroderma(1) |
total | 622 | 51% | 30.2 ± 18.6 |  |